Search
Genenta Science SPA
GNTAAdd to Watchlist
1.720USD
-0.030-1.71%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
40.30MMarket Cap
LossP/E TTM
More Details of Genenta Science SPA Company
Genenta Science SpA is an Italy-based company engaged in clinical-stage biotechnology research. The Company focuses on the development of lentivirus-based gene and cell therapies in cancer. It uses gene-based cytokine delivery to activate the immune system within the tumor providing the anti-tumor response. The Company not only operates locally but also is present in global markets, including the United States.
Genenta Science SPA Info
Ticker SymbolGNTA
Company nameGenenta Science SPA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Number of employees13
Security typeDepository Receipt
Fiscal year-endDec 15
AddressVia Olgettina 58
CityMILANO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryItaly
Postal code20132
Phone
Websitehttps://www.genenta.com/
Ticker SymbolGNTA
IPO dateDec 15, 2021
CEOParacchi (Pierluigi)
Company Executives of Genenta Science SPA
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
Dr. Armon Reza Sharei, Ph.D.
Dr. Armon Reza Sharei, Ph.D.
Independent Director
Independent Director
--
--
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
--
--
Ms. Barbara Regonini
Ms. Barbara Regonini
Finance Director
Finance Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Pierluigi Paracchi
Mr. Pierluigi Paracchi
Chairman of the Board, Chief Executive Officer, General Manager
Chairman of the Board, Chief Executive Officer, General Manager
2.43M
+5.34%
Dr. Carlo Russo, M.D.
Dr. Carlo Russo, M.D.
Chief Medical Officer, Head of Development
Chief Medical Officer, Head of Development
602.42K
+0.66%
Mr. Richard B. Slansky
Mr. Richard B. Slansky
Chief Financial Officer
Chief Financial Officer
22.15K
--
Dr. Stefania Mazzoleni, Ph.D.
Dr. Stefania Mazzoleni, Ph.D.
Scientific Project Manager, Communication Officer
Scientific Project Manager, Communication Officer
--
--
Dr. John Louis Cantello, Ph.D.
Dr. John Louis Cantello, Ph.D.
Independent Director
Independent Director
--
--
Dr. Lauren Haeyong Chung, Ph.D.
Dr. Lauren Haeyong Chung, Ph.D.
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Genenta Science SPA?
The top five shareholders of Genenta Science SPA are: Mr. Pierluigi Paracchi
How many institutions hold shares of Genenta Science SPA (GNTA)?
As of 2026Q1, 24 institutions hold shares of Genenta Science SPA, with a combined market value of approximately 3.34M, accounting for 14.15% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1015532.00.